BOULDER, Colo.--MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska. The funding supports the refinement of the MBio platform and improvements in manufacturing as [...]

PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA(R) (pembrolizumab) SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma. The assay is now approved [...]

Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today announced the completion of a $34 million Series A financing round. “We’re pleased to announce the successful completion of our Series A Round,” said Tammy Lee, President and CEO of Recombinetics. “This financing will allow us to accelerate commercialization of this transformative science to [...]

Advancing science and healthcare in a region with increasing demands for modern molecular testing solutions Hilden, Germany, and Johannesburg, South Africa – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the appointment of The Scientific Group, a South Africa-based company and wholly owned subsidiary of Ascendis Medical, as its exclusive commercial partner for Africa, excluding [...]

Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The companies have focused [...]

- HORIBA New Jersey Optical Spectroscopy Center to Open - HORIBA, Ltd. (Head Office: Kyoto, Japan; hereinafter, “HORIBA”) announced today the relocation of its development and production center for optical analysis and measurement instruments. The relocation will take place within the U.S. state of New Jersey, moving from Edison to Piscataway, with the Center becoming [...]

NEW YORK -- Spheryx, Inc. announced today that the National Science Foundation (NSF) has awarded the company a Phase II-B Small Business Innovation Research (SBIR) grant for $500,000 over 2 years. This new grant is a continuation of an earlier grant entitled "Total Holographic Characterization of Colloids Through Holographic Video Microscopy" and is for the [...]

San Francisco, CA Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics, a clinical-stage biotechnology company, has adopted Genedata as their preferred bioinformatics solution provider. Aptevo will use the Genedata Biologics® platform to facilitate expansion of their pipeline of novel bispecific antibody candidates focused on immuno-oncology, autoimmune disease and inflammation. [...]

LANSING, Mich. — Neogen’s revolutionary Listeria Right Now™ environmental pathogen detection system has officially achieved AOAC approval, license number #081802. The approval adds another level of assurance to the food safety community, as the product has now been validated by one of the industry’s leading third-party accreditation groups. “It’s extremely gratifying to receive this approval,” said John Adent, [...]

TORONTO--Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to work together on multiple projects, initially focusing on the enhancement of Invicro’s AmyloidIQ and TauIQ platforms. EBG will be responsible for providing data from their affiliate companies; [...]